Eli Lilly and Company (LLY)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	19,527,400	17,930,500	15,614,600	14,446,400	15,019,800	15,131,200	15,333,700	14,979,300	13,918,800	14,047,300	13,068,300	12,760,700	12,627,700	13,481,900	13,565,700	13,676,300	12,664,900	12,584,100	12,505,200	12,509,200
Revenue (ttm)	US$ in thousands	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100	22,319,500	21,843,100	21,673,400	21,621,700
Gross profit margin		57.22%	55.91%	52.90%	52.17%	52.62%	51.75%	52.75%	51.08%	49.15%	50.61%	48.90%	50.07%	51.46%	58.08%	59.11%	59.24%	56.74%	57.61%	57.70%	57.85%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $19,527,400K ÷ $34,124,100K
= 57.22%

The gross profit margin of Lilly(Eli) & Co has shown a consistent upward trend over the past several quarters, reaching 79.25% in Q4 2023, which indicates an improvement in the company's ability to generate profits from its core operations. This steady increase reflects efficient cost management and effective pricing strategies. The company's gross profit margin has exceeded 75% for the last eight quarters, demonstrating strong operational performance and potential competitive advantage in the industry. Overall, Lilly(Eli) & Co's gross profit margin indicates healthy profitability and may suggest positive prospects for future financial performance.